• Adrenoleukodystrophy Newborn Screening in California Since 2016: Programmatic Outcomes and Follow-Up.
  Matteson Jamie et al. International journal of neonatal screening 2021 7(2)
• Spinal Muscular Atrophy.
  Nicolau Stefan et al. Seminars in pediatric neurology 2021 37100878
• Implementing newborn screening for sickle cell disease in Korle Bu Teaching Hospital, Accra: Results and lessons learned.
  Segbefia Catherine I et al. Pediatric blood & cancer 2021 e29068
• "We needed this": perspectives of parents and healthcare professionals involved in a pilot newborn screening program for spinal muscular atrophy
  Kariyawasam Didu S T et al. EClinicalMedicine 2021 33100742
• Rare disease awareness and perspectives of physicians in China: a questionnaire-based study.
  Li Xuefeng et al. Orphanet journal of rare diseases 2021 16(1) 171
• The benefits and challenges of family genetic testing in rare genetic diseases-lessons from Fabry disease.
  Germain Dominique P et al. Molecular genetics & genomic medicine 2021 e1666
• Impact of newborn screening for cystic fibrosis on clinical outcomes of pediatric patients: 10 years' experience in Lodz Voivodship.
  Olszowiec-Chlebna M et al. Italian journal of pediatrics 2021 47(1) 87
• Newborn screening for spinal muscular atrophy in Germany: clinical results after 2 years.
  Vill Katharina et al. Orphanet journal of rare diseases 2021 16(1) 153
• Discordant results between conventional newborn screening and genomic sequencing in the BabySeq Project.
  Wojcik Monica H et al. Genetics in medicine : official journal of the American College of Medical Genetics 2021
• Increased detection of primary carnitine deficiency through second-tier newborn genetic screening.
  Lin Yiming et al. Orphanet journal of rare diseases 2021 16(1) 149

More